Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2026-02-20 @ 6:57 AM
Study NCT ID:
NCT02559856
Status:
COMPLETED
Last Update Posted:
2025-11-17
First Post:
2015-09-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparison of Bleeding Risk Between Rivaroxaban and Apixaban: The Pilot Study
Sponsor:
Ottawa Hospital Research Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
COBRRA Pilot
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None